variant,gene_symbol,summary,clinical_importance,evidence,impact,frequency,category,inheritance,zygosity,PMIDs,dbSNP_ID,penetrance_score,build_37_chromosome,build_37_position,build_37_variant_allele,getev_report_url
ATP7B-T991M,ATP7B,"Reported to cause Wilson's disease in a recessive manner, a disorder where copper accumulation leads to neurological and liver dysfunction. This effect is recorded in ClinVar by LabCorp (http://www.ncbi.nlm.nih.gov/clinvar/RCV000029361/).",High,Uncertain,Pathogenic,,"Mouth, liver, and digestive;Nervous system",Recessive,Heterozygous,,,5,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
C3-R102G,C3,"This variant (also called C3F) is common in Europeans (10.2% allele frequency), and is associated with age-related macular degeneration. In the US, 1.5% of adults over 40 have the disease, but the incidence increases strongly with age (>15% in women over 80). Assuming an average lifetime risk of ~10%, heterozygous individuals have a ~13% risk and homozygous have ~20%.",Moderate,Likely,Pathogenic,0.15,Hearing and vision,Complex/Other,Heterozygous,4427677;17634448,rs2230199,3,chr19,6718387,C,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
MYO1A-G662E,MYO1A,"Although one report speculated that this variant may cause dominant, early-onset sensorineural hearing loss, the findings lacked statistical significance. Notably, this gene is not a clinically tested gene and another of the eight variants reported by these authors (S797F) has since been observed in a PGP participant with no symptoms of hearing loss.",Moderate,Uncertain,Pathogenic,0.026,Hearing and vision;Nervous system,Dominant,Heterozygous,12736868,rs33962952,5,chr12,57431402,T,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
SIAE-M89V,SIAE,"This variant was reported to be associated with autoimmune disease when homozygous. However, a later publication has contradicted this result, finding no significant association between this variant and autoimmune disease in a very large cohort.",Moderate,Uncertain,Pathogenic,0.04,Immune system,Recessive,Heterozygous,20555325;22200769,rs78778622,3,chr11,124530664,C,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
PPARG-P12A,PPARG,,Moderate,Uncertain,Not Reviewed,0.089,Other,Unknown,Heterozygous,16783862;17213274;17463248,rs1801282,3,chr3,12393125,G,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
HFE-C282Y,HFE,"This variant is associated with hereditary haemochromatosis, 80% of patients with that disease are homozygous for this variant. However, the penetrance is low, in Beutler et al. they note that only 1 of their 158 homozygotes met criteria for diagnosis with the condition.",Low,Well-established,Pathogenic,0.049,Blood,Recessive,Heterozygous,11313265;11812557;18025780,rs1800562,1,chr6,26093141,A,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
KRT5-G138E,KRT5,"This variant is associated with 1.25x increased risk of basal cell carcinoma (common skin cancer, rarely malignant).",Low,Likely,Pathogenic,0.052,Cancer;Skin,Unknown,Heterozygous,19578363,rs11170164,3,chr12,52913668,T,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
FANCG-R513Q,FANCG,"Rare polymorphism. Hypothesized to increase susceptibility to childhood acute myeloid leukemia, but the numbers in the study failed to have statistical significance.",Low,Uncertain,Pathogenic,0.0072,Blood;Cancer,Dominant,Heterozygous,16643430,rs17885240,2,chr9,35075022,T,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
POLG-Q1236H,POLG,"Generally a nonpathogenic polymorphism, but may have a modifier effect that increases severity when combined in cis with other pathogenic variants.",Low,Uncertain,Pathogenic,0.058,Other,Complex/Other,Heterozygous,15917273;16595552,rs3087374,0,chr15,89859994,A,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
TGIF1-P83Shift,TGIF1,"Severe variants in this gene are associated with holoprosencephaly disorders when combined with loss-of-function variants in SHH. Haploinsufficiency was identified in some families with this condition. It is unclear how likely this variant is to occur in combination with an SHH variant, or what phenotypic effect the variant would have on its own.",Low,Uncertain,Pathogenic,0.14,Nervous system,Complex/Other,Heterozygous,10556296,rs11571510,1,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
ELAC2-S217L,ELAC2,"Reported to be associated with increased susceptibility to prostate cancer, but later studies weaken the hypothesis. Xu et al.'s meta-analysis concludes that there is a small but significant increased risk (OR = 1.13). Assuming a lifetime risk of 16% for prostate cancer we calculate this leads to an increased risk of ~1.5% (17.5% total).",Low,Uncertain,Pathogenic,0.27,Cancer;Genital and urinary,Complex/Other,Heterozygous,12384782;15368467;18767027;20231859,rs4792311,2,chr17,12915009,A,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
ATM-S49C,ATM,May be associated with a small increased risk of breast cancer.,Low,Uncertain,Pathogenic,0.01,Cancer,Complex/Other,Homozygous,16652348;20826828,rs1800054,1,chr11,108098576,G,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
SP110-L425S,SP110,"This variant is associated with a slightly increased risk of tuberculosis. It is unclear whether it is itself causal, or in linkage disequilibrium with some other causal variant that has a stronger effect.",Low,Uncertain,Pathogenic,0.86,Immune system,Unknown,Heterozygous,16803959,rs3948464,1,chr2,231050715,G,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
BRCA2-N372H,BRCA2,"This is a common variant of BRCA2 (HapMap allele frequency of 23%). The variant is weakly associated with an increased chance of breast cancer, and zygosity of the variant is associated with sex of children: male children are more likely to be homozygous for this variant, female children are more likely to be heterozygous.",Low,Uncertain,Pathogenic,0.24,Cancer,Recessive,Heterozygous,11062481;15235023,rs144848,2,chr13,32906729,C,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
ELAC2-A541T,ELAC2,"This variant is implicated as causing increased susceptibility to prostate cancer. However the variant has always been seen paired with S217L, it is unclear which variant is causal. Evidence is weak for both; one meta-analysis (Severi et al.) concluded that neither variant was pathogenic, a more recent meta-analysis (Xu et al.) found the data to be significant but the odds ratio was not strong and concluded they are ""low-penetrance susceptibility markers of prostate cancer"".",Low,Uncertain,Pathogenic,0.028,Cancer;Genital and urinary,Unknown,Heterozygous,10986046;11175785;11431329;12373607;12515253;12783937;18767027;20231859,rs34152967,2,chr17,12899902,T,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
CPN1-G178D,CPN1,"This rare variant (around 1% allele frequency) is hypothesized to cause carboxypeptidase N deficiency in a recessive manner, especially if combined with a more severe variant. However the findings lack statistical sigificance: only a single case study of an affected individual links this variant to causing the disease. There arenâ€™t any follow-up in vitro studies testing whether this variant affects protein function.",Low,Uncertain,Pathogenic,0.036,Metabolism,Recessive,Heterozygous,12560874,rs61751507,5,chr10,101829514,T,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
CLEC7A-Y238X,CLEC7A,This variant has been found to impair homan mucosal antifungal defense and was implicated in vulvovaginal candidiasis and mucocutaneous infections in a Dutch family.,Low,Uncertain,Pathogenic,0.063,Genital and urinary;Skin,Recessive,Heterozygous,19864674,rs16910526,4,chr12,10271087,C,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
ERCC6-R1213G,ERCC6,"When homozygous, this variant may cause Cockayne Syndrome, which is a severe autosomal-recessive disorder characterized by abnormal early growth and development, abnormal sensitivity to sunlight, and premature aging. Cockayne Syndrome Type I and Type II lead to death in early childhood. Several other variants in the ERCC6 gene are linked to Cockayne Syndrome. This variant may also be linked to age-related macular degeneration like other ERCC6 variants, and has been linked to colorectal cancer in one study. ",Low,Uncertain,Pathogenic,0.2,Anatomical and congenital;Cancer;Hearing and vision,Recessive,Heterozygous,,rs2228527,0,chr10,50678369,C,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
H6PD-R453Q,H6PD,"This common variant may have a small pathogenic effect by contributing to cortisone reductase deficiency (a rare abnormality) when homozygous and combined with a serious pathogenic variant. The same authors have tested and ruled out a contribution to polycystic ovary syndrome (similar phenotype, more common disease).",Low,Uncertain,Pathogenic,0.31,Genital and urinary;Metabolism,Recessive,Heterozygous,12858176;15827106;16817821,rs6688832,1,chr1,9323910,A,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
TP53-P72R,TP53,"This is a common variant was first reported as a polymorphism. It has since had mixed associations with cancer: Storey et al. conclude a 7x *increased* risk of HPV cancer for homozygotes vs hets, but Jones et al. find a 1.98x *decreased* risk for colorectal cancer. This variant may have significant impact on particular cancers, but it is unclear what effect it has on the overall burden of cancer.",Low,Uncertain,Pathogenic,0.63,Cancer,Unknown,Homozygous,1975675;9607760;15355915;19837266;20615891;22184967,rs1042522,0,chr17,7579472,C,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
WFS1-R611H,WFS1,"This nonsynonymous SNP is associated with Wolfram Syndrome (known as DIDMOAD), which is characterized by early-onset non-autoimmune diabetes mellitus, diabetes insipidus, optic atrophy, and deafness) and to adult Type Two Diabetes Mellitus.  The WFS1 gene maps to chromosome 4p16.3.  The variant has been shown to be statistically associated with type II diabetes in six UK studies and one study of Ashkenazi Jews (Sandhu, M., et al., Minton et al.).",Low,Uncertain,Not Reviewed,0.4,Hearing and vision;Immune system;Metabolism,Recessive,Heterozygous,17603484;17719176;23257691,rs734312,1,chr4,6303354,A,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
CYP2C9-R144C,CYP2C9,"This variant, also called CYP2C9*2, is a pharmacogenetic variant that modulates sensitivity for Warfarin (due to reduced metabolism). This variant is associated with Caucasians. The FDA has approved reduced recommended Warfarin dosage based on the presence of this variant.",Moderate,Well-established,Pharmacogenetic,0.097,Drug response;Metabolism,Unknown,Heterozygous,8004131;15947090;17161452;17686967;19228618;19794411;19794412,rs1799853,3,chr10,96702047,T,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
ABCC6-R1268Q,ABCC6,This common polymorphism appears to not have a significant phenotypic impact. A few studies report weak but significant associations with plasma lipids (in Inuits) and thalidomide toxicity.,Low,Uncertain,Pharmacogenetic,0.22,Metabolism,Unknown,Homozygous,10811882;10913334;11776382;20038957,rs2238472,1,chr16,16251599,T,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
rs1544410,,"rs1544410 is a Vitamin D Receptor (VDR) single nucleotide polymorphism. It is unlikely that it has functional significance because it is located in an intron (Liu et. al.), but it is in strong linkage disequilibrium with rs731236 (Dvornyk et al), which is located in an exon. ",Low,Uncertain,Pharmacogenetic,0.35,Other,Unknown,Heterozygous,,rs1544410,0,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
PRNP-M129V,PRNP,"This variant is associated with some protective effects for prion disease -- individuals homozygous for this variant are less susceptible to Creutzfeldt-Jakob, and Papua New Guinea individuals heterozygotes at this site are less susceptible to kuru.

",Low,Well-established,Protective,0.34,Other,Complex/Other,Heterozygous,18236005;19081515,rs1799990,0,chr20,4680251,G,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
NPC1-H215R,NPC1,"This variant is associated with a reduced risk of obesity, with an additive effect of -0.084 BMI per allele (an average of 0.54 pounds less, per allele, in a 5'6"" individual).





",Low,Likely,Protective,0.3,Metabolism,Complex/Other,Heterozygous,19151714;19174833;19910939,rs1805081,2,chr18,21140432,C,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
IL7R-T244I,IL7R,"The reference genome variant for this allele has been associated with a slight increased risk of multiple sclerosis. Thus, this variant can be treated as a ""protective"" variant -- carriers of this variant are slightly less likely to have MS. Because the disease is rare and the effect of this variant is not very strong, the absolute decreased risk for carriers of this variant is less than .05% (less than 1 in 2000).",Low,Likely,Protective,0.21,Immune system;Nervous system,Unknown,Heterozygous,12825072;17660530;17660816;17660817;21161391,rs6897932,0,chr5,35874575,T,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
ABCG5-R50C,ABCG5,This variant has a mild protective effect on blood cholesterol. It is associated with slightly lower total and LDL cholesterol levels.,Low,Likely,Protective,0.068,Blood;Metabolism,Unknown,Heterozygous,19060911,rs6756629,1,chr2,44065090,A,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
DTNBP1-P272S,DTNBP1,Possibly a slight protective effect against colorectal cancer if homozygous.,Low,Uncertain,Protective,0.035,Cancer,Recessive,Heterozygous,17000706,rs17470454,2,chr6,15523448,A,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
ARSA-N350S,ARSA,This common variant (HapMap 24.1% allele frequency) causes a loss of a glycosylation site (affecting the size of the protein when studied with gel electrophoresis) but does not affect enzyme activity or stability.,Low,Well-established,Benign,0.18,Other,Unknown,Heterozygous,2574462,rs2071421,,chr22,51064416,C,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
ADA-D8N,ADA,"This common variant is reported to reduce adenosine deaminase enzyme activity. It has been associated with an increased tendency for non-REM sleep -- more slow wave sleep, less nocturnal wakings, and a stronger negative impact of sleep deprivation. A role for this gene and variant was previously proposed for autism susceptibility, but this is controversial and was not replicated by later studies.",Low,Likely,Benign,0.03,Nervous system,Dominant,Heterozygous,7316475;8031011;11354825;16221767;17340203;21359089;21734253,rs73598374,,chr20,43280227,T,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
NEFL-S472Shift,NEFL,"Although a frameshift in this gene would be predicted to cause Charcot-Marie Neuropathy, this particular position appears to reflect a single base insertion error/mutation in the reference genome (in other words, normal individuals are always homozygous for a deletion at this position relative to reference). See chr8:24,811,060-24,811,080 annotations on UCSC.",Low,Likely,Benign,,Nervous system,Unknown,Homozygous,,rs11340767,,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
PKP2-D26N,PKP2,"Probably benign. This variant has been classified as a rare polymorphism, although other variants in this gene have been implicated in causing autosomal dominant arrhythmogenic right ventricular dysplasia (which can cause sudden death at an early age).",Low,Likely,Benign,0.0049,Heart and circulatory,Unknown,Heterozygous,16567567;20829228,,,chr12,33049590,T,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
CACNA1S-L458H,CACNA1S,Common polymorphism,Low,Likely,Benign,0.27,Other,Unknown,Heterozygous,,rs12742169,,chr1,201052310,T,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
MLH1-I219V,MLH1,"Computational evidence, functional assays, and case/control studies suggest this variant is probably benign.",Low,Uncertain,Benign,0.24,Other,Dominant,Heterozygous,11781295;12810663;17074586;17510385;17870204;19863800;20301390;22631669,rs1799977,0,chr3,37053568,G,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
LOXL1-R141L,LOXL1,"Associated with exfoliative glaucoma & syndrome (XFG & XFS) in various populations, but with contradicting results (protective in Caucasians, pathogenic in Japanese). Based on this it seems the variation itself -- although it affects protein structure -- is not itself causing disease. Instead it is likely associated with other nearby causal variants. As such, it is evaluated as benign by GET-Evidence (which focuses on reporting causal variants). See detailed variant report for disease risk associations.",Low,Uncertain,Benign,0.26,Hearing and vision,Complex/Other,Heterozygous,17690259;18450598;20142848,rs1048661,,chr15,74219546,T,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
FMO3-V257M,FMO3,"This common variant (HapMap allele frequency of 9.2%) appears to have no functional effect. OMIM has recorded it as having been seen homozygously in an individual with Trimethylaminuria, but Treacy et al. 1998 conclude it is a polymorphism.",Low,Uncertain,Benign,0.057,Metabolism,Unknown,Heterozygous,9536088,rs1736557,,chr1,171080080,A,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
ERCC6-R1230P,ERCC6,Probably benign.,Low,Uncertain,Benign,0.07,Other,Unknown,Heterozygous,,rs4253211,,chr10,50678317,G,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
GJB3-R32W,GJB3,"Probably benign. Although Polyphen 2 predicts it be damaging and some publications suggested it might have a functional effect, others report it to be a fairly common polymorphism and functional studies failed to find a difference between it and wild type.",Low,Uncertain,Benign,0.022,Other,Unknown,Heterozygous,10888284;11175305;12702148,rs1805063,,chr1,35250457,T,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
TPCN2-G734E,TPCN2,Pigmentation allele.,Low,Uncertain,Benign,0.29,Other,Unknown,Heterozygous,18488028,rs3829241,,chr11,68855363,A,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
APOB-Y1422C,APOB,This position is almost certainly an error in the HG18 reference sequence. ,Low,Uncertain,Benign,1.0,Other,Unknown,Homozygous,,rs568413,,chr2,21235475,C,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
COL7A1-P1277L,COL7A1,"Polymorphism, presumed benign.",Low,Uncertain,Benign,0.041,Other,Unknown,Heterozygous,,rs35761247,,chr3,48623124,A,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
SLC45A2-L374F,SLC45A2,"Pigmentation allele for non-black hair, and consequently, possible increased susceptibility to malignant melanoma.",Low,Uncertain,Benign,0.69,Cancer,Unknown,Homozygous,15714523;17044855;18563784;18806926,rs16891982,,chr5,33951693,G,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
PKP2-L366P,PKP2,This variant is a benign polymorphism.  ,Low,Uncertain,Benign,0.22,Other,Unknown,Heterozygous,19955750,rs1046116,,chr12,33021934,G,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
PCSK9-G670E,PCSK9,This variant is likely benign. ,Low,Uncertain,Benign,0.89,Other,Unknown,Homozygous,19351729,rs505151,,chr1,55529187,A,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
PALB2-E672Q,PALB2,Probably benign.,Low,Uncertain,Benign,0.024,Other,Unknown,Heterozygous,17200668,rs45532440,,chr16,23641461,G,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
TYR-S192Y,TYR,This variant is reported to affect skin pigmentation. It is associated with lighter skin in South Asians (OR 4-5) and with a lack of freckles in Europeans (OR 1.3).,Low,Uncertain,Benign,0.27,Skin,Unknown,Heterozygous,17952075;17999355,rs1042602,,chr11,88911696,A,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
RP1-N985Y,RP1,"Probably benign. One report linked this variant to high triglycerides, but a later paper found a nearby SNP with similar association and suggests that both findings are caused by linkage to an undiscovered causal variant.",Low,Uncertain,Benign,0.35,Metabolism,Unknown,Heterozygous,12764676;19364639,rs2293869,,chr8,55539395,T,http://evidence.pgp-hms.org/genomes?display_genome_id=c0233333d35a15761e1c30d6c4946109d8ee40d9
